■ We have revised our commodity price and FX forecasts, mainly to include actual Q1/14 prices. Please refer to our industry note entitled "Revising FX & Commodity Price Forecasts" for further details.
■ Our Q1/14, 2014 and 2015 EBITDA estimates go to $29M (from $28M), $130M (from $131M), and $186M (from $189M), respectively.
■ Our DCPS estimates for Q1/14 remain the same at $0.10, while our 2014E and 2015E numbers go to $0.44 (from $0.52) and $0.71 (from $0.73), respectively.
■ We believe it would be in Canexus' best interest to cut its dividend by ~50% to enhance its financial flexibility given the amount of capital spending remaining and ramp-up phase.
Recommendation
■ We maintain our SP rating pending contract announcements and completion of Bruderheim. We have lowered our target marginally to $6.70 (from $7.00), based on 1.0x NAV.
■ We believe a significant dividend cut is already discounted in CUS' share price at these levels and that the market would react positively.